-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, an authoritative journal in the field of neurology published a research article in Annals of Neurology, which aims to evaluate the pathophysiological mechanism of ischemic stroke in cancer patients .
Stroke
The researchers conducted a prospective cross-sectional study of two hospitals from 2016 to 2020, and recruited three groups with 50 adult participants in each group.
The outcome of the study was pre-designated blood biomarkers and transcranial Doppler microembolization detection.
Thrombotic vascular
Biomarker levels in each group
The levels of all studied biomarkers differ between the groups.
It can be seen that compared with the corresponding control group, cancer-related stroke patients have higher levels of coagulation, platelet and endothelial dysfunction markers, and more circulating microthrombi .
Compared with the corresponding control group, cancer-related stroke patients have higher levels of coagulation, platelet and endothelial dysfunction markers, and more circulating microthrombi
Original source:
Original source:Babak B.